Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, discusses how Patients Should Still Test for BRCA Mutations They are in increased risk of breast cancer.
Patients Should Still Test for BRCA Mutations They are in increased risk of breast cancer
